SuperworthGenpact LTD EPS G
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $3.37
- Latest quarter, Q2 FY26
- $0.86
- +15% on a year earlier
- Fiscal year 2025
- $3.13
- +10% on the year before
Genpact LTD's earnings per share was $3.37 over the twelve months to Jun 30, 2026, up 12% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.86, up 15% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 15% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $3.13 | +10% |
| FY2024 | $2.84 | −17% |
| FY2023 | $3.43 | +82% |
| FY2022 | $1.88 | −2% |
| FY2021 | $1.91 | +22% |
| FY2020 | $1.57 | +1% |
| FY2019 | $1.56 | +8% |
| FY2018 | $1.45 | +8% |
| FY2017 | $1.34 | +4% |
| FY2016 | $1.29 | +18% |
| FY2015 | $1.09 | +28% |
| FY2014 | $0.85 | −13% |
| FY2013 | $0.98 | +26% |
| FY2012 | $0.78 | −4% |
| FY2011 | $0.81 | +29% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.86 | +15% | $3.37 | |
| Q1 FY26 | $0.86 | +18% | $3.26 | |
| Q4 FY25 | $0.82 | +4% | $3.13 | |
| Q3 FY25 | $0.83 | +12% | $3.10 | |
| Q2 FY25 | $0.75 | +12% | $3.01 | |
| Q1 FY25 | $0.73 | +14% | $2.93 | |
| Q4 FY24 | $0.79 | −50% | $2.84 | |
| Q3 FY24 | $0.74 | +16% | $3.64 | |
| Q2 FY24 | $0.67 | +6% | $3.54 | |
| Q1 FY24 | $0.64 | +12% | $3.50 | |
| Q4 FY23 | $1.59 | +231% | $3.43 | |
| Q3 FY23 | $0.64 | +25% | $2.32 |
Against its peers
Companies in Consulting Services nearest Genpact LTD's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GGenpact LTD | $3.37 | +12% a year |
| BAHBooz Allen Hamilton | $6.38 | −22% a year |
| FCNFTI Consulting | $8.27 | +16% a year |
| EXPOExponent | $2.23 | +12% a year |
| HURNHuron Consulting | $6.67 | +16% a year |
| EFXEquifax | $5.69 | +11% a year |
| ASTHAstrana Health | $0.82 | +61% a year |
| ICFIICF International | $4.83 | −16% a year |
| BWMNBowman Consulting | $0.40 | −34% a year |
| Peer median | $5.26 |
Where Genpact LTD ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Genpact LTD
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.